Table 1 Baseline characteristics of Study Population.
From: A randomized trial of a mobile health intervention to augment cardiac rehabilitation
Intervention | Control | |
|---|---|---|
Age, years | 59.5 (10.7) | 59.7 (10.5) |
Sex, N (%) | ||
Male | 75 (67.6%) | 78 (71.6%) |
Female | 36 (32.4%) | 31 (28.4%) |
Race, N (%) | ||
Asian | 6 (5.4%) | 3 (2.8%) |
Black | 4 (3.6%) | 8 (7.3%) |
White | 92 (82.9%) | 92 (84.4%) |
Other | 9 (8.1%) | 6 (5.5%) |
Ethnicity, N (%) | ||
Hispanic Ethnicity | 2 (1.8%) | 1 (0.9%) |
Non-Hispanic Ethnicity | 104 (93.7%) | 104 (95.4%) |
Unknown | 5 (4.5%) | 4 (3.7%) |
Study site, N (%) | ||
Michigan Medicine | 90 (81.1%) | 85 (78.0%) |
Spectrum Health | 21 (18.9%) | 24 (22.0%) |
Phone type, N (%) | ||
iPhone (Apple Watch Series 4) | 70 (63.1%) | 68 (62.4%) |
Android phone (Fitbit Versa 2) | 41 (36.9%) | 41 (37.6%) |
Indication for cardiac rehabilitation, N (%) | ||
Percutaneous coronary intervention | 58 (2.3%) | 47 (43.1%) |
Coronary artery bypass grafting | 21 (18.9%) | 18 (16.5%) |
Valve repair or replacement | 22 (19.8%) | 27 (24.8%) |
Percutaneous coronary intervention or coronary artery bypass grafting & valve repair or replacement | 3 (2.7%) | 3 (2.8%) |
Coronary artery disease or acute coronary syndrome, not revascularized | 7 (6.3%) | 14 (12.8%) |
Body mass index, kg/m2, a | 30.4 (6.5) | 30.9 (7.3) |
Comorbidities, N (%) | ||
Atrial fibrillation/fluttera | 29 (26.1%) | 22 (20.2%) |
Coronary artery disease/Myocardial infarction | 92 (82.9%) | 81 (74.3%) |
Diabetes mellitusa | 31 (27.9%) | 31 (28.4%) |
Hypertensiona | 74 (66.7%) | 68 (62.4%) |
Heart failure | 21 (18.9%) | 17 (15.6%) |
History of valve repair or replacement | 29 (26.1%) | 29 (26.6%) |
